BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38089570)

  • 1. Wild-type C-Raf gene dosage and dimerization drive prostate cancer metastasis.
    Ta L; Tsai BL; Deng W; Sha J; Varuzhanyan G; Tran W; Wohlschlegel JA; Carr-Ascher JR; Witte ON
    iScience; 2023 Dec; 26(12):108480. PubMed ID: 38089570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras assemblies and signaling at the membrane.
    Nussinov R; Tsai CJ; Jang H
    Curr Opin Struct Biol; 2020 Jun; 62():140-148. PubMed ID: 32032914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
    Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
    Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA
    Biochim Biophys Acta; 2007 Aug; 1773(8):1263-84. PubMed ID: 17126425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
    Poulikakos PI; Zhang C; Bollag G; Shokat KM; Rosen N
    Nature; 2010 Mar; 464(7287):427-30. PubMed ID: 20179705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration.
    Mooz J; Oberoi-Khanuja TK; Harms GS; Wang W; Jaiswal BS; Seshagiri S; Tikkanen R; Rajalingam K
    Sci Signal; 2014 Aug; 7(337):ra73. PubMed ID: 25097033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
    Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals.
    Illario M; Cavallo AL; Monaco S; Di Vito E; Mueller F; Marzano LA; Troncone G; Fenzi G; Rossi G; Vitale M
    J Clin Endocrinol Metab; 2005 May; 90(5):2865-73. PubMed ID: 15687337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of Raf activation through dimerization.
    Zhang M; Maloney R; Jang H; Nussinov R
    Chem Sci; 2021 Dec; 12(47):15609-15619. PubMed ID: 35003591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK-1 activates C-Raf through a Ras-independent mechanism.
    Leicht DT; Balan V; Zhu J; Kaplun A; Bronisz A; Rana A; Tzivion G
    Biochim Biophys Acta; 2013 May; 1833(5):976-86. PubMed ID: 23360980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors.
    Yuan X; Tang Z; Du R; Yao Z; Cheung SH; Zhang X; Wei J; Zhao Y; Du Y; Liu Y; Hu X; Gong W; Liu Y; Gao Y; Huang Z; Cao Z; Wei M; Zhou C; Wang L; Rosen N; Smith PD; Luo L
    Mol Oncol; 2020 Aug; 14(8):1833-1849. PubMed ID: 32336014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy.
    Huang Y; Zhen Y; Chen Y; Sui S; Zhang L
    Biochem Pharmacol; 2023 Nov; 217():115842. PubMed ID: 37802240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
    Garnett MJ; Rana S; Paterson H; Barford D; Marais R
    Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes.
    Tordai A; Franklin RA; Patel H; Gardner AM; Johnson GL; Gelfand EW
    J Biol Chem; 1994 Mar; 269(10):7538-43. PubMed ID: 8125975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
    Kiel C; Serrano L
    Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black Rice Anthocyanins Suppress Metastasis of Breast Cancer Cells by Targeting RAS/RAF/MAPK Pathway.
    Chen XY; Zhou J; Luo LP; Han B; Li F; Chen JY; Zhu YF; Chen W; Yu XP
    Biomed Res Int; 2015; 2015():414250. PubMed ID: 26649302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the C-Raf N Region Promotes Raf Dimerization.
    Takahashi M; Li Y; Dillon TJ; Kariya Y; Stork PJS
    Mol Cell Biol; 2017 Oct; 37(19):. PubMed ID: 28694330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.